Lipotype is going to Maastricht, Netherlands!
As of May, we began rolling out our fully overhauled lipidomics data reports. After months of intensive work, the data science team incorporated many improvements – from clear design, to new analyses, reworked data structure, and much more.
It has been already more than two years since the world was shocked by COVID-19. With countless infections and deaths worldwide, there are cases reported regarding long-term effects in some patients.
Lipotype is going to Seoul, South Korea!
We at Lipotype believe that human life and health are the highest values. In March we have purchased and sent 10.000 EUR worth of medical supplies and medications including defibrillators, first aid kits, wound dressing materials, medications for cardiovascular emergencies, and first-line medications for the people living with chronic diseases. These supplies have been delivered through our extended network to the regional hospital in Lviv.
As a proud sponsoring partner of the 10th Neurodegenerative Drug Development Summit (NDD) in Boston, Lipotype is attending this event from 28th to 30th March.
As a pioneer in the field of lipidomics, Lipotype not only provides lipidomic analysis services to customers but also contributes to science through carrying out its own research.
Lipotype launched new analysis packages for population health studies.
We all know that genes and proteins are important in biological research. But what about lipids? Lipidomics has proven its usefulness in many studies, but still a lot of scientists do not know about lipidomics and have no clear picture of how it will benefit their research. Hence, we newly launched a webinar series, The Lipidomics Webinar.
Even in the midst of a global crisis, COVID-19, there are people who try to make the best of it.